Clinical Trial Search

Primary: Difference in BDD Severity (BDD-YBOCS) at the End of Treatment/Waitlist Period. — 29.85; 30.85; 23.77; 27.13 score on a scale — p=<.0001

Primary: Body Dysmorphic Disorder Symptoms (as Measured by the BDD-YBOCS) — 32.21; 31.49; 26.92; 27.27 score on a scale — p=<.01

Primary: Treatment Completion Rates — 10 Participants

Primary: Body Dysmorphic Disorder Yale-Brown Obsessive Compulsive Scale (BDD-YBOCS) — 19.64; 18.77 units on a scale

Primary: Number of Binge Eating and Self-induced Vomiting Episodes — 20.67; 31.33; 21.67; 36.67 number of episodes

Primary: Number of Responders on the Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) — 9 Participants

Primary: Body Dysmorphic Disorder Modification of the Yale-Brown Obsessive Compulsive Disorder Scale — 18.42 score on a scale — p=<0.001

Primary: Treatment Responder — 9; 4 Participants

Primary: Emotion Recognition Questionnaire — 18.67; 17.00; 17.00; 16.40 score on a scale

Primary: Change in Mental Health-related Quality of Life From Baseline to 24 Weeks — 8.87; 8.39 units on a scale — p=0.002

Primary: Phase II Relapse of Body Dysmorphic Disorder (BDD) Symptoms (as Measured by the BDD-YBOCS) — 18; 40 percentage of subjects who relapsed — p=0.048

Primary: Visual Analog Scale for Pain — 75; 75; 75; 46 mm — p=<0.001

Primary: Yale Brown Obsessive Compulsive Scale (Modified for BDD) (BDD -YBOCS) (Phillips et al., 1997) — 23.47; 32.87; 21.37; 33.30 units on a scale — p=<.001

Primary: Change in Total Score on the BDD-Y-BOCS Scale — -12.27; -9.53 units on a scale

Primary: Self-Ratings of Thought Appraisals (Believability) — 78.33; 77.97; 83.23; 74.74 score on a scale — p=<0.001